- Home
- Slides
- Home
- Tools and Resources
- Research Summaries for Consumers, Clinicians, and Policymakers
- Search for Research Summaries, Reviews, and Reports
- Research Available for Comment
- Submit a Suggestion for Research
- Submit Scientific Information Packets
- Comparative Effectiveness Research Grant and ARRA Awards
- News and Announcements
- What Is Comparative Effectiveness Research
- Who Is Involved in the Effective Health Care Program
- What Is the Effective Health Care Program
Slides
Authors: John I. Gomez, MD
Slides: 1–12 of 45
Outline of Material
Keywords: rheumatoid arthritis | RA | DMARDs | disease-modifying | antirheumatic | anti-rheumatic | rheumatic | biologic | oral
Health Impact of Rheumatoid Arthritis
Keywords: rheumatoid arthritis | RA | DMARDs | disease-modifying | antirheumatic | anti-rheumatic | prevalence
Treatment of Rheumatoid Arthritis
Keywords: rheumatoid arthritis | RA | DMARDs | disease-modifying | antirheumatic | anti-rheumatic | rheumatic | biologic | oral | corticosteroids
DMARDs in Rheumatoid Arthritis Treatment (1 of 2)
Keywords: rheumatoid arthritis | RA | DMARDs | disease-modifying | antirheumatic | anti-rheumatic | rheumatic | biologic | oral
DMARDs in Rheumatoid Arthritis Treatment (2 of 2)
Keywords: rheumatoid arthritis | RA | DMARDs | disease-modifying | antirheumatic | anti-rheumatic | rheumatic | biologic | oral | cytokines | TNF-alpha | tumor necrosis factor-alpha | interleukin 1 | IL-1 | interleukin 6 | IL-6 | CD20 | CD28
Oral DMARDs Included in the Comparative Effectiveness Review
Keywords: anti-rheumatic | antirheumatic | biologic | cytokine synthesis | dihydrofolate reductase | disease-modifying | DMARDs | folate metabolism | hydroxychloroquine | leflunomide | lymphocyte function | methotrexate | oral | pyridine synthesis | RA | rheumatic | sulfasalazine | T-lymphocytes | rheumatoid arthritis
Biologic DMARDs Included in the Comparative Effectiveness Review
Keywords: rheumatoid arthritis | RA | DMARDs | disease-modifying | antirheumatic | anti-rheumatic | rheumatic | biologic | tumor necrosis factor-alpha | TNF-alpha | TNF-a | adalimumab | etanercept | infliximab | abatacept | anakinra | rituximab | tocilizumab
Agency for Healthcare Research and Quality (AHRQ) Comparative Effectiveness Review (CER) Development
Keywords: comparative effectiveness review | systematic review
Rating the Strength of Evidence From the Comparative Effectiveness Review
Keywords: strength of evidence | comparative effectiveness
Clinical Questions Addressed by the Comparative Effectiveness Review
Keywords: rheumatoid arthritis | RA | DMARDs | disease-modifying | antirheumatic | anti-rheumatic | rheumatic | biologic | oral | demographics | comorbidities
Clinically Significant Outcomes of Interest in the Comparative Effectiveness Review
Keywords: rheumatoid arthritis | RA | DMARDs | disease-modifying | antirheumatic | anti-rheumatic | rheumatic | biologic | oral | disease activity | ACR | radiographic evidence of progression | functional capacity | HAQ | quality of life | SF-36 | DAS
Your slide tray is being processed.